PreveCeutical Medical (TSE:PREV) has released an update.
PreveCeutical Medical Inc. announced an update on the Management Cease Trade Order, citing a delay in filing their 2023 annual financial reports due to funding issues. They have since secured funds through a private placement and expect to complete the filings by June 28, 2024. Trading continues for the general public, but restrictions apply to company insiders until filings are complete.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.
